US Patent Issued to SOTIO BIOTECH on May 12 for "Humanized CLDN18.2 antibodies" (Swiss, Czech, German Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,100, issued on May 12, was assigned to SOTIO BIOTECH A.S. (Prague). "Humanized CLDN18.2 antibodies" was invented by Lukas Bammert (Basel, Sw... Read More

US Patent Issued to Celex Oncology Innovations on May 12 for "Monoclonal antibodies against neonatal Na v 1.5" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,101, issued on May 12, was assigned to Celex Oncology Innovations Ltd. (London). "Monoclonal antibodies against neonatal Na v 1.5" was inven... Read More

US Patent Issued to Rutgers, The State University of New Jersey on May 12 for "CD147 chimeric antigen receptors and methods of use" (New Jersey Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,102, issued on May 12, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.). "CD147 chimeric antigen receptors ... Read More

US Patent Issued to Yuhan on May 12 for "Engineered antibodies that bind LAG3" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,103, issued on May 12, was assigned to Yuhan Corp. (Seoul, South Korea). "Engineered antibodies that bind LAG3" was invented by Damien Bress... Read More

US Patent Issued to LENTIGEN TECHNOLOGY, THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services on May 12 for "Compositions and methods for treating cancer with anti-CD19 immunotherapy" (Maryland, Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,104, issued on May 12, was assigned to LENTIGEN TECHNOLOGY INC. (Gaithersburg, Md.) and THE UNITED STATES OF AMERICA, as represented by the S... Read More

US Patent Issued to Kite Pharma on May 12 for "Chimeric antigen and t cell receptors and methods of use" (California, New Hampshire Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,105, issued on May 12, was assigned to Kite Pharma Inc. (Santa Monica, Calif.). "Chimeric antigen and t cell receptors and methods of use" w... Read More

US Patent Issued to Amgen on May 12 for "Combination of LILRB1/2 pathway inhibitors and PD-1 pathway inhibitors" (Canadian, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,106, issued on May 12, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Combination of LILRB1/2 pathway inhibitors and PD-1 pathway inhi... Read More

US Patent Issued to Bristol-Myers Squibb on May 12 for "Cancer immunotherapy by disrupting PD-1/PD-L1 signaling" (Pennsylvania, Maryland, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,107, issued on May 12, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Cancer immunotherapy by disrupting PD-1/PD-L1 signaling"... Read More

US Patent Issued to New York University, PureTech LYT on May 12 for "Anti-galectin-9 antibodies and uses thereof" (American, British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,108, issued on May 12, was assigned to New York University (New York) and PureTech LYT Inc. (Boston). "Anti-galectin-9 antibodies and uses t... Read More

US Patent Issued to ABL Bio on May 12 for "Antibody to insulin-like growth factor 1 receptor (IGF1R) and related compositions and uses" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,110, issued on May 12, was assigned to ABL Bio Inc. (Seongnam-si, South Korea). "Antibody to insulin-like growth factor 1 receptor (IGF1R) a... Read More

• ««
• «
• 2140
• 2141
• 2142
• 2143
• 2144
• 2145
• 2146
• 2147
• 2148
• 2149
• »
• »»